{"disease":{"id":"solid-tumors-harboring-somatic-her2-or-egfr-exon-18-mutations","name":"solid tumors harboring somatic her2 or egfr exon 18 mutations"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01953926","title":"Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":582,"lead_sponsor_name":"Puma Biotechnology, Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}